All
Research
Education
Forschung
Lehre
Business
Lösungen
DE
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Türkçe
JA - 日本語
PL - Polski
RU - Русский
HE - עִברִית
AR - العربية
Anmelden
Department of Cellular Therapy,
Department of Oncology,
Department of Cellular Therapy, Department of Oncology
Else-Marit Inderberg has not added Biography.
If you are Else-Marit Inderberg and would like to personalize this page please email our Author Liaison for assistance.
Phase I/IIa clinical trial of a novel hTERT peptide vaccine in men with metastatic hormone-naive prostate cancer.
Cancer immunology, immunotherapy : CII Jul, 2017 | Pubmed ID: 28391357
A TCR-based Chimeric Antigen Receptor.
Scientific reports Sep, 2017 | Pubmed ID: 28878363
Human c-SRC kinase (CSK) overexpression makes T cells dummy.
Cancer immunology, immunotherapy : CII Apr, 2018 | Pubmed ID: 29248956
Artesunate shows potent anti-tumor activity in B-cell lymphoma.
Journal of hematology & oncology Feb, 2018 | Pubmed ID: 29458389
Oslo University Hospital-Radiumhospitalet
Pierre Dillard1,
Hakan Köksal1,
Else-Marit Inderberg1,
Sebastien Wälchli1
1Department of Cellular Therapy, Department of Oncology, Oslo University Hospital-Radiumhospitalet
Datenschutz
Nutzungsbedingungen
Richtlinien
Kontakt
BIBLIOTHEKS-EMPFEHLUNG
JoVE-Newsletter
JoVE Journal
Methodensammlungen
JoVE Encyclopedia of Experiments
Archiv
JoVE Core
JoVE Science Education
JoVE Lab Manual
JoVE Quiz
JoVE Playlist
Autoren
Bibliothekare
Zugang
ÜBER JoVE
JoVE Sitemap
Copyright © 2025 MyJoVE Corporation. Alle Rechte vorbehalten